| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |